68Ga-A9-3202

N/A

Report date: 2025/11/20 16:00:33

NME

Base Information

Drug Name68Ga-A9-3202

Drug Alias Name68 Ga-A9-3202A9-320268Ga-A9-320268Ga-A9T-320268Ga A9 3202

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionMelanocortin receptor 1 bindersPositron-emission tomography enhancers

TargetsMelanocortin receptor 1

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlpha-9 Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpha-9 Oncology Inc

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A